Seerum Institute of India to Invest $68 Million in Britain’s Oxford Biomedica

Serum Institute of India is headquartered in Puna, Maharashtra. Adar Poonawalla’s company is the world’s largest vaccine manufacturer.

Seerum Institute of India to Invest $68 Million in Britain's Oxford Biomedica
Seerum Institute of India to Invest $68 Million in Britain’s Oxford Biomedica (Photo: PTI)

India’s vaccine manufacturing company, Serum Institute of India (SII) will invest $68 million in Oxford Biomedica. The UK’s vaccine maker said on Wednesday that SII has agreed to fund the development of a COVID-19 vaccine plant.

As part of the deal, Serum Life Sciences Ltd, a unit of SII, will be getting a 3.9% stake in Oxford Biomedica.

According to the British company, the fund will be used to develop a new space in its Oxbox plant into a vaccine manufacturing space, which is expected to be ready for manufacturing in mid-2023

Based in Pune, India, Serum Institute of India is the world’s largest producer of vaccine in terms of volume. SII and Oxford Biomedica together produce AstraZeneca’s COVID-19 vaccine.

Keep visiting The Ganga Times for Business News, India News, and World News. Follow us on FacebookTwitter, and Instagram for regular updates.

Leave a Reply

Your email address will not be published. Required fields are marked *